Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-00948 |
APOC3 Protein, Human, Recombinant (His & SUMO)
Apolipoprotein C3,Apo-CIII,Apolipoprotein C-III, |
Human | E. coli |
APOC3 Protein, Human, Recombinant (His & SUMO) is expressed in E. coli expression system with N-6xHis-SUMO tag. The predicted molecular weight is 24.8 kDa and the accession number is P02656. | |||
TMPH-02420 |
APOC3 Protein, Cynomolgus, Recombinant (His & SUMOstar)
ApoC-III,APOC3,Apolipoprotein C-I... |
Cynomolgus | P. pastoris (Yeast) |
APOC3 Protein, Cynomolgus, Recombinant (His & SUMOstar) is expressed in yeast with N-6xHis-SUMOSTAR tag. The predicted molecular weight is 24.7 kDa and the accession number is P18659. | |||
TMPH-02516 |
APOC3 Protein, Mouse, Recombinant (His & SUMO)
APOC3,ApoC-III,Apolipoprotein C |
Mouse | E. coli |
APOC3 Protein, Mouse, Recombinant (His & SUMO) is expressed in E. coli expression system with N-6xHis-SUMO tag. The predicted molecular weight is 24.9 kDa and the accession number is P33622. | |||
TMPY-04310 |
Apolipoprotein A-IV/APOA4 Protein, Human, Recombinant (His)
apolipoprotein A-IV |
Human | HEK293 Cells |
Apolipoprotein is genetically associated with the risk of Alzheimer's disease (AD). The APOA1, APOC3, and APOA4 genes are closely linked and located on human chromosome 11. There was a decreased trend for levels of APOA1, APOC3, and APOA4 in AD patients. CONCLUSION: Low levels of APOA1, APOC3, and APOA4 are associated with risk of AD. APOA1, APOC3, and APOA4 should be developed as combined drugs for the therapy of AD. SNP(single nucleotide polymorphisms)in APOA1and APOA4 genes influences atherog... |